Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

NCT04143282 is registered in ClinicalTrials.gov with Hager salah el din as lead sponsor.

NCT NCT04143282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04143282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Lead sponsor
Hager salah el din
Phase
Phase 2
Overall status
Completed
Start date
October 20, 2019
Completion date
June 30, 2020
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer